首页|蔡连香教授基于"微癥瘕"理论分阶段治疗中重度宫腔粘连临证经验

蔡连香教授基于"微癥瘕"理论分阶段治疗中重度宫腔粘连临证经验

扫码查看
宫腔粘连(Intrauterine adhesions,IUA)临床发病率逐年增高,严重影响女性生殖健康和妊娠结局,宫腔镜检查是诊断金标准,宫腔镜宫腔粘连分离术是治疗宫腔粘连的首选方法,但术后降低复粘率、改善内膜状态是临床关注重点,也是亟待解决的难点.蔡连香教授认为宫腔粘连表现为胞宫瘀阻,瘀久成癥,基本病机是肾虚气弱,推动无力.创新性提出宫腔粘连的"微癥瘕"理论,临床上分阶段辨证施治中重度宫腔粘连:宫腔粘连分解术后,治以益气活血化瘀、消癥散结以预防复粘;宫腔形态恢复正常时,治以补肾调经、活血养血以修复内膜,提高内膜容受性,临床疗效满意.
Professor Cai Lianxiang's Clinical Experience in Treating Moderate to Severe Intra-uterine Adhesion in Stages Based on Theory of"Micro Zhengjia"
The clinical incidence of intrauterine adhesion(IUA)has been increasing annually,seriously impacting women's reproductive health and pregnancy outcomes.Hysteroscopy is the gold standard for diagnosis,and hysteroscopic adhesiolysis is the preferred treatment for IUA.However,reducing the recurrence rate of adhesions and improving endome-trial conditions after surgery are key clinical concerns and difficult challenges that urgently need to be addressed.Professor Cai Lianxiang believes that IUA is characterized by blood stasis and obstruction in the uterus,with prolonged stasis leading to the formation of masses.The fundamental pathogenesis involves kidney deficiency and Qi weakness,resulting in insuffi-cient power for movement.She innovatively proposed the"micro Zhengjia"theory for IUA and advocated a staged,syn-drome-differentiated treatment for moderate to severe cases.After hysteroscopic adhesion separation,the treatment focuses on tonifying Qi,promoting blood circulation,resolving stasis,and dissolving masses to prevent recurrence.Once the uterine cavity has returned to its normal shape,the treatment shifts to tonifying the kidneys,regulating menstruation,promoting blood circulation,and nourishing the blood to repair the endometrium and improve endometrial receptivity.The clinical re-sults have been satisfactory.

Professor Cai LianxiangIntrauterine AdhesionMicro ZhengjiaKidney Deficiency and Blood StasisStaged TreatmentExperience of Famous Doctor

胥丽霞、黄欲晓、蔡连香、高山凤、辛雪艳、席艳雪、杨琪、朱馥丽

展开 >

中国中医科学院西苑医院,北京 100091

蔡连香教授 宫腔粘连 微癥瘕 肾虚血瘀 分阶段治疗 名医经验

中国中医科学院科技创新工程

CI2021A02409

2024

世界中西医结合杂志
中华中医药学会

世界中西医结合杂志

CSTPCD
影响因子:1.053
ISSN:1673-6613
年,卷(期):2024.19(8)
  • 13